Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

NCT00103935 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: placebo
DRUG: placebo
DRUG: Exenatide LAR
DRUG: Exenatide LAR

Sponsor

AstraZeneca

Collaborators

[object Object]